Skip to main content
Medicines, medical devices

Guidance and regulation

Skip to results
412 results sorted by Most viewed
  • How to make a payment by credit or debit card or a bank transfer for all applications except Device Registration and Certificates of Free Sale applications.

  • Information on applying for New Active Substance Work Sharing Initiative (NASWSI) and Biosimilar Work Sharing Initiative (BSWSI) assessments and list of approved products.

  • A digital platform designed to facilitate the reporting, monitoring, and management of medical device incidents.

  • How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.

  • The Early Access to Medicines Scheme (EAMS) aims to give patients with life threatening or seriously debilitating conditions early access to medicines that show early signs of having a major advantage over existing therapeut…

  • How to get a marketing authorisation (MA) for an advanced therapy medicinal product (ATMP) so it can be sold and/or supplied in the United Kingdom.

  • Webinar recordings providing information about plans for implementing the new Clinical Trial Regulations.

  • Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.

  • Information on comparator products used in studies supporting abridged marketing authorisation application.

  • A step-by-step guide on using the MORE Platform for Submissions of device related incidents.

  • How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines

  • A list of herbal medicines currently holding a traditional herbal registration (THR) granted by the Medicines and Healthcare products Regulatory Agency (MHRA).

  • Information on the new regulations for the post-market surveillance of medical devices which come into effect on 16 June 2025.

  • What you need to do before your product can be placed on the Great Britain market with a UKCA mark.

  • There are changes to the legislation on reference medicinal products (RMPs) used to support abridged marketing authorisation applications.

  • Details of the organisations that are currently approved to undertake conformity assessments on medical devices.

  • How to renew marketing authorisations for products granted through different routes and at different times.

  • How to write clear and effective field safety notices (FSNs) for medical devices.

  • How to change the ownership from one marketing authorisation (MA) holder to another.

  • How to register as a manufacturer, importer or distributor of active substances.